Specialty Focus Target large payer and provider networks in HIV, Hepatitis C, cancer, and rare diseases where Aureus already concentrates services, presenting opportunities to expand therapy management, mail order efficiency, and patient adherence programs.

Mid-market Scale With 51-200 employees and revenue in the 10–25 million range, position Aureus as a growth partner for mid-market health plans and regional health systems seeking specialized pharmaceutical care without unlocking enterprise-scale complexity.

Regional Footprint Leverage existing facilities in multiple states (PA NY NJ MO) to offer expanded geographic coverage, faster fulfillment, and co-located care coordination for patients, payors, and manufacturers.

Technology Levers Utilize current tech stack (WordPress, analytics, forms, and web assets) to streamline lead capture, patient onboarding, and program enrollment, while offering data-driven outcomes reporting for payors and manufacturers.

Partnership Potential Align with manufacturers and payors seeking specialized distribution and therapy management for HIV, HCV, cancer, and rare conditions; propose joint go-to-market programs, risk-sharing models, and co-funded adherence initiatives.